Award Recipients

Jane Lock received the Rosow award.  This award recognizes students that exemplify the leadership and academic qualities we seek to foster in our graduate students. Dr. Carl Rosow, for whom the award is named, is an MD, PhD, BUSM graduate and Professor of Anesthesiology at Harvard Medical School. Since 1985, Dr. Rosow has honored his doctoral mentor Dr. Joseph Cochin, an internationally recognized authority on opioids, by teaching this subject to medical students in the second-year BUSM curriculum and donating his honorarium to the school. The Carl E. Rosow Award for Pharmacology Education serves both to honor graduate students for their excellence in teaching pharmacology and Dr. Rosow for his continued service to his alma mater and its students.  Jane is an MD/PhD candidate in the Program in Biomolecular Pharmacology conducting thesis research in the lab of Dr. Rachel L. Flynn.

Jess Floro received the Levinsky Fellowship. This award was established in memory of Norman Levinsky, MD who was Chair of the Department of Medicine from 1972-1997. During his tenure he supported the development of basic research programs in the Department of Medicine, including the Graduate Program in Molecular and Translational Medicine. The Levinsky fellowship was initiated in memory of Dr. Levinsky with the goal of supporting graduate education in the department.   This fellowship provides educational support, and is awarded to the top-ranked first year PhD student as assessed by the Admissions Committee of the program. Jess is a PhD candidate in the Graduate Program in Molecular and Translational Medicine conducting thesis research in the lab of Dr. Rachel L. Flynn.

Ryan Quinton received the Doctoral Foreign Study Award from the Canadian Institutes of Health Research. Ryan is an MD/PhD Predoctoral Student in Dr. Neil Ganem’s laboratory in the Department of Pharmacology & Experimental Therapeutics and was one of 10 students performing biomedical research abroad to receive this prestigious award. The award will support Ryan for the next three years while he investigates the role of the Hippo tumor suppressor pathway in breast cancer development.